Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fenoterol in asthma.

G Anderson, E Wilkins, A G Jariwalla

    British Journal of Diseases of the Chest
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Fenoterol, a beta 2-sympathomimetic bronchodilator, significantly improved lung function in asthma patients compared to placebo. It demonstrated greater efficacy and duration than terbutaline, with minimal side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Verification imaging in prostate MR-only radiotherapy: Are fiducial markers necessary?

    Radiography (London, England : 1995)·2024
    Same author

    The first patients treated with MR-CBCT soft-tissue matching in a MR-only prostate radiotherapy pathway.

    Radiography (London, England : 1995)·2023
    Same author

    Is stopping secondary prophylaxis safe in HIV-positive talaromycosis patients? Experience from Myanmar.

    HIV medicine·2020
    Same author

    Integration of HIV services with primary care in Yangon, Myanmar: a retrospective cohort analysis.

    HIV medicine·2020
    Same author

    Associations between food environment typologies and body mass index: Evidence from Yorkshire, England.

    Social science & medicine (1982)·2019
    Same author

    Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.

    HIV medicine·2016
    Same journal

    Apical pulmonary fibrosis in psoriasis.

    British journal of diseases of the chest·1988
    Same journal

    Progressive apical pleural fibrosis: a 'constrictive' ventilatory defect.

    British journal of diseases of the chest·1988
    Same journal

    Induction of bronchial hyperresponsiveness following smoke inhalation injury.

    British journal of diseases of the chest·1988
    Same journal

    Chronic beryllium disease in identical twins.

    British journal of diseases of the chest·1988
    Same journal

    Pleuropulmonary haemangiopericytoma masquerading as a post-infective encysted pleural effusion.

    British journal of diseases of the chest·1988
    Same journal

    Massive haemoptysis in the acquired immunodeficiency syndrome.

    British journal of diseases of the chest·1988
    See all related articles

    Area of Science:

    • Pharmacology
    • Respiratory Medicine
    • Clinical Trials

    Background:

    • Asthma involves reversible airway obstruction.
    • Beta 2-sympathomimetic bronchodilators are used for asthma management.
    • Fenoterol and terbutaline are common bronchodilators.

    Purpose of the Study:

    • To compare the efficacy of fenoterol and terbutaline in asthmatic patients.
    • To evaluate the bronchodilator effects on peak expiratory flow rate (PEFR).
    • To assess patient-reported symptom relief and side effects.

    Main Methods:

    • Double-blind, cross-over trial design.
    • 17 patients with reversible airway obstruction.
    • Inhalation of fenoterol (0.4 mg), terbutaline (0.5 mg), and placebo.

    Related Experiment Videos

    Main Results:

    • Both fenoterol and terbutaline significantly increased PEFR compared to placebo.
    • Fenoterol demonstrated a greater increase and longer duration of PEFR response than terbutaline.
    • Patients reported symptom relief with active bronchodilators; side effects were minimal.

    Conclusions:

    • Fenoterol is an effective bronchodilator for asthma.
    • Fenoterol may offer superior efficacy and duration compared to terbutaline at the tested doses.
    • Fenoterol provides symptomatic relief with a favorable safety profile.